Bioxytran Inc (BIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 986 | 1,058 | 750 | 1,094 | -14 |
| Operating Income | -986 | -1,058 | -750 | -1,094 | 14 |
| Interest Expense | 49 | 40 | 67 | 56 | 44 |
| Other Income | -94 | -351 | -1 | 285 | -173 |
| Pre-tax Income | -1,128 | -1,448 | -818 | -866 | -203 |
| Net Income Continuous | -1,128 | -1,448 | -818 | -866 | -203 |
| Minority Interests | -35 | -1 | -33 | -51 | -80 |
| Net Income | $-1,093 | $-1,447 | $-785 | $-815 | $-124 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | N/A | 0.00 |
| EPS Basic Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | N/A | 0.00 |
| EPS Diluted Continuous Ops | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 |
| EBITDA(a) | $-984 | $-707 | $-750 | $-1,079 | $187 |